Feb 25, 2026
On Monday, Gilead Sciences Inc. (NASDAQ:GILD) announced it is acquiring Arcellx Inc. (NASDAQ:ACLX) to enhance its long-term oncology prospects. Gilead currently owns approximately 11.5% of Arcellx’s outstanding common stock. Multi-Billion…
Stellantis N.V. (NYSE:STLA) stock tanked Friday after the automaker warned of a full-year net loss, flagging a sweeping business reset that includes roughly 22 billion…
British pharmaceutical giant GSK Plc (NYSE:GSK) on Wednesday reported fourth-quarter core earnings of 68 cents (25.5 pence), outperforming the consensus forecast of 64 cents. Earnings…
In today's rapidly changing and highly competitive business world, it is vital for investors and industry enthusiasts to carefully assess companies. In this article, we…